Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity
Effect on an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity: a Randomized Clinical Study
1 other identifier
interventional
75
1 country
1
Brief Summary
This randomized, single-blind, placebo-controlled clinical trial aims to clinically evaluate the effect of an experimental gel containing copaiba oleo-resin in the control of dentin hypersensitivity (DH) in non-carious cervical lesions (NCCL). Seventy-five hypersensitive teeth will be selected into three groups (N=25) and approved in three treatment sessions. The groups will be: GROUP P= water-soluble placebo gel without active ingredient; GROUP KF2: Potassium nitrate 5% + Sodium fluoride 2%; GROUP GC: Gel containing copaiba oleo-resin. A visual analogue scale (VAS) will be used to compare the DH after tactile stimulation with an exploratory probe and evaporative stimulation with air jets. The DH assessments will be performed at four times: baseline, after 1 week, 15 days and 30 days after the beginning of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Sep 2024
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2024
CompletedFirst Submitted
Initial submission to the registry
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 12, 2025
CompletedMay 20, 2025
March 1, 2025
6 months
January 16, 2025
May 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
sensitivity assessment
Evaluation of hypersensitivity in teeth with non-carious cervical lesions. Patients will be instructed to complete a form to record tooth sensitivity before the application of the gels. An evaluation will be performed at baseline, 7 days, 15 days and 30 days, based on their individual perception of pain. The evaluation form will consist of a visual analogue scale (VAS). This scale consists of a 10 cm horizontal line with points of 0 and 10 at its ends, where 0 means no sensitivity and 10 means severe tooth sensitivity. The patient will be instructed to draw a vertical line along the horizontal line of the scale, recording the intensity of tooth sensitivity. So that the distance in millimeters from the zero end can later be measured with the aid of a millimeter ruler, thus obtaining the intensity level of the patient's back.
30 days
Study Arms (3)
Placebo gel
PLACEBO COMPARATORthe group will receive the application of gel without active ingredient
KF2 (Potassium nitrate gel)
ACTIVE COMPARATORthe group will receive the application of gel containing potassium nitrate
Copaiba gel
EXPERIMENTALthe group will receive the application of gel containing copaiba
Interventions
will receive the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.
will receive application of potassium nitrate gel on hypersensitive dental surfaces, in an active way, for 10 minutes.
will receive the application of the experimental desensitizing gel on the vestibular surfaces of the hypersensitive teeth in an active manner, for 10 minutes.
Eligibility Criteria
You may qualify if:
- hypersensitive areas on the vestibular surface of the teeth with exposed cervical dentin up to 1 mm deep and/or class I gingival recession according to the Miller classification;
- individuals who have at least two hypersensitive teeth
- periodontal health,
- good general physical health;
- willingness to participate in the research by providing written informed consent;
- no eating disorders or very acidic diets
You may not qualify if:
- presence of restorations;
- presence of dental caries and periodontal pockets;
- ongoing treatment with antibiotics and/or anti-inflammatory and/or analgesic drugs;
- professional desensitizing treatment received three months prior to the study;
- pregnancy or lactation; systemic diseases;
- pulpitis;
- use of orthodontic appliances or dental prostheses that may interfere with the assessment of hypersensitivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal Do Para
Belém, Pará, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cecy M Silva, Doctor
universidade federal do pará
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of the Graduate Program in Dentistry at the Federal University of Pará
Study Record Dates
First Submitted
January 16, 2025
First Posted
March 12, 2025
Study Start
September 20, 2024
Primary Completion
March 10, 2025
Study Completion
March 10, 2025
Last Updated
May 20, 2025
Record last verified: 2025-03